TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2017

A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.

K H Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.